Summary
In 1999, during the ARIA (Allergic Rhinitis and its Impact on Asthma) WHO workshop, an evidence-based document was produced using an extensive review of the literature available up to December of the same year. An update of the ARIA guidelines was soon needed and started in 2004. Thereafter, there was the need for an even more global document, which would highlight the interactions between the upper and the lower airways including diagnosis, epidemiology, common risk factors, management and prevention, and comprise the allergy perspective also for developing countries. This goal was achieved with the most recently published ARIA update 2008. The present article is the result of consecutive efforts of the authors of the ARIA update 2008 to accomplish the nationwide comprehensive distribution of information by publication in important national journals, like the WMW.
Zusammenfassung
Im Jahr 1999 wurde innerhalb des "Allergic Rhinitis and its Impact on Asthma (ARIA)" WHO-Workshops ein evidenzbasiertes Dokument erstellt, welches einen umfangreichen Überblick über die Literatur zum Thema allergische Rhinitis bis Dezember 1999 gibt. Eine Aktualisierung der ARIA-Richtlinien aus dem Jahre 1999 war allerdings notwendig. Die ARIA-Aktualisierung wurde im Jahr 2004 begonnen. Danach zeigte sich die Notwendigkeit eines globalen Dokuments, welches die Interaktion zwischen oberen und unteren Atemwegserkrankungen aufzeigt, inklusive Diagnose, Epidemiologie, allgemeine Risikofaktoren, Management und Prävention. Zusätzlich sollte auch die Allergieperspektive in Entwicklungsländern angesprochen werden. Die Aktualisierung von ARIA (ARIA-Aktualisierung 2008), welche diese genannten Aspekte abdeckt, wurde kürzlich publiziert. Diesen Autoren ist es ein ausdrückliches Anliegen, auf diese Richtlinien über Kurzzusammenfassungen – wie der vorliegenden – in wichtigen nationalen Journalen wie der WMW hinzuweisen.
Similar content being viewed by others
Literatur
Hansel F. Clinical and histopathologic studies of the nose and sinuses in allergy. J Allergy, 1: 43–70, 1929
Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy, 62(Suppl 85): 17–25, 2007
Dorner T, Rieder A, Lawrence K, et al. Österreichischer Allergiebericht. Wien: Verein Altern mit Zukunft, 2006
Maurer M, Zuberbier T. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy, 62: 1057–1063, 2007
The International Study of Asthma and Allergies in Childhood Steering Committee I. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet, 351: 1225–1232, 1998
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol, 108: S147–S334, 2001
Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J, 24: 758–764, 2004
Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet, 368: 733–743, 2006
van Ree R, Yazdanbakhsh M. Allergic disorders in African countries: linking immunology to accurate phenotype. Allergy, 62: 237–246, 2007
Shekelle PG, Woolf SH, Eccles M, et al. Clinical guidelines: developing guidelines. Bmj, 318: 593–596, 1999
Custovic A, Wijk RG. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy, 60: 1112–1115, 2005
Passalacqua G, Bousquet PJ, Carlsen KH, et al. ARIA update: I – Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol, 117: 1054–1062, 2006
Bonini S, Bonini M, Bousquet J, et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy, 61: 681–692, 2006
Bousquet J, van Cauwenberge P, Ait Khaled N, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy, 61: 1086–1096, 2006
Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol, 119: 881–891, 2007
Cruz AA, Popov T, Pawankar R, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy, 62(Suppl 84): 1–41, 2007
Demoly P, Allaert FA, Lecasble M, et al. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy, 58: 672–675, 2003
Bachert C, van Cauwenberge P, Olbrecht J, et al. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy, 61: 693–698, 2006
Todo-Bom A, Loureiro C, Almeida MM, et al. Epidemiology of rhinitis in Portugal: evaluation of the intermittent and the persistent types. Allergy, 62: 1038–1043, 2007
Van Hoecke H, Vastesaeger N, Dewulf L, et al. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J Allergy Clin Immunol, 118: 758–759, 2006
Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol, 120: 359–365, 2007
Bonini M, Lapucci G, Petrelli G, et al. Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. Allergy, 62: 1166–1170, 2007
Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol, 120: 863–869, 2007
Chatkin MN, Menezes AM, Victora CG, et al. High prevalence of asthma in preschool children in Southern Brazil: a population-based study. Pediatr Pulmonol, 35: 296–301, 2003
Giovannini M, Agostoni C, Riva E, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res, 62: 215–220, 2007
Choi SH, Yoo Y, Yu J, et al. Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors. Allergy, 62: 1051–1056, 2007
Bateman ED, Jithoo A. Asthma and allergy–a global perspective. Allergy, 62: 213–215, 2007
English RG, Fairall LR, Bateman ED. Keeping allergy on the agenda: integrated guidelines for respiratory disease in developing countries. Allergy, 62: 224–229, 2007
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN* and AllerGen**) doi:10.1111/j.1398-9995.2007.01620.x. Allergy, 63: 8–160, 2008
Schunemann HJ, Hill SR, Kakad M, et al. Transparent development of the WHO rapid advice guidelines. PLoS Med, 4: e119, 2007
Brozek JL, Baena-Cagnani CE, Bonini S, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy, 63: 38–46, 2008
Kaiser HB, Naclerio RM, Given J, et al. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol, 119: 1430–1437, 2007
Fokkens WJ, Jogi R, Reinartz S, et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy, 62: 1078–1084, 2007
Devillier P, Bousquet J. Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy? Clin Exp Allergy, 37: 400–414, 2007
Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol, 114: 838–844, 2004
Walter Canonica G, Bousquet J, Van Hammee G, et al. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med, 100: 1706–1715, 2006
Virchow JC, Bachert C. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir Med, 100: 1952–1959, 2006
Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin, 20: 1549–1558, 2004
Barnes ML, Menzies D, Fardon TC, et al. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy, 62: 73–80, 2007
Durham SR, Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy, 62: 954–957, 2007
Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol, 117: 802–809, 2006
Dahl R, Kapp A, Colombo G, et al. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol, 121: 512–518 e2, 2008
Dahl R, Kapp A, Colombo G, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol, 118: 434–440, 2006
Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol, 120: 1338–1345, 2007
Calamita Z, Saconato H, Pela AB, et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy, 61: 1162–1172, 2006
Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy, 62: 317–324, 2007
Molgaard E, Thomsen SF, Lund T, et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy, 62: 1033–1037, 2007
Greiner AN, Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol, 118: 985–998, 2006
Casale TB, Romero FA, Spierings EL. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol, 121: 105–109, 2008
Linneberg A, Jorgensen T, Nielsen NH, et al. The prevalence of skin-test-positive allergic rhinitis in Danish adults: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. Allergy, 55: 767–772, 2000
Terreehorst I, Oosting AJ, Tempels-Pavlica Z, et al. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy, 32: 1160–1165, 2002
Georgy V, Fahim HI, El-Gaafary M, et al. Prevalence and socioeconomic associations of asthma and allergic rhinitis in northern [corrected] Africa. Eur Respir J, 28: 756–762, 2006
Kuyucu S, Saraclar Y, Tuncer A, et al. Epidemiologic characteristics of rhinitis in Turkish children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol, 17: 269–277, 2006
Antonicelli L, Micucci C, Voltolini S, et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy, 37: 954–960, 2007
Antonicelli L, Micucci C, Voltolini S, et al. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy, 62: 1064–1070, 2007
Stelmach R, do Patrocinio TNM, Ribeiro M, et al. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest, 128: 3140–3147, 2005
Camargos P, Ibiapina C, Lasmar L, et al. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy, 62: 310–316, 2007
Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10- year follow-up on the PAT study. Allergy, 62: 943–948, 2007
Civelek E, Soyer OU, Gemicioglu B, et al. Turkish physicians' perception of allergic rhinitis and its impact on asthma. Allergy, 61: 1454–1458, 2006
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pali-Schöll, I., Pohl, W., Aberer, W. et al. Die Auswirkungen von allergischer Rhinitis auf Asthma (ARIA-Aktualisierung 2008). Die österreichische Perspektive. Wien Med Wochenschr 159, 87–92 (2009). https://doi.org/10.1007/s10354-009-0646-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10354-009-0646-z